SlideShare a Scribd company logo

Modeling survival of hemodialysis patients

•Download as PPT, PDF•
•
Christos Argyropoulos
Christos Argyropoulos

Presentation given ca 2008 during my fellowship at UPMC. Explains some of the methodologies in my 2009 JASN paper

1 of 32
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients
Modeling survival of hemodialysis patients

Recommended

Choosing Regression Models
Choosing Regression ModelsChoosing Regression Models
Choosing Regression ModelsStephen Senn
 
Urinalysis
UrinalysisUrinalysis
UrinalysisChristos Argyropoulos
 
Interpretation of renal diagnostic tests
Interpretation of renal diagnostic testsInterpretation of renal diagnostic tests
Interpretation of renal diagnostic testsChristos Argyropoulos
 
Update: International Year of Sustainable Tourism for Development 2017
Update: International Year of Sustainable Tourism for Development 2017Update: International Year of Sustainable Tourism for Development 2017
Update: International Year of Sustainable Tourism for Development 2017World Tourism Organziation
 
Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationChristos Argyropoulos
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxChristos Argyropoulos
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIVChristos Argyropoulos
 
RNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseRNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseChristos Argyropoulos
 

Recommended

Choosing Regression Models
Choosing Regression ModelsChoosing Regression Models
Choosing Regression ModelsStephen Senn
 
Urinalysis
UrinalysisUrinalysis
UrinalysisChristos Argyropoulos
 
Interpretation of renal diagnostic tests
Interpretation of renal diagnostic testsInterpretation of renal diagnostic tests
Interpretation of renal diagnostic testsChristos Argyropoulos
 
Update: International Year of Sustainable Tourism for Development 2017
Update: International Year of Sustainable Tourism for Development 2017Update: International Year of Sustainable Tourism for Development 2017
Update: International Year of Sustainable Tourism for Development 2017World Tourism Organziation
 
Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationChristos Argyropoulos
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxChristos Argyropoulos
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIVChristos Argyropoulos
 
RNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseRNA Biomarkers in Chronic Kidney Disease
RNA Biomarkers in Chronic Kidney DiseaseChristos Argyropoulos
 
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsChristos Argyropoulos
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateChristos Argyropoulos
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesChristos Argyropoulos
 
Survival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsSurvival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsChristos Argyropoulos
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021 Christos Argyropoulos
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesChristos Argyropoulos
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021Diabetic kidney disease 2021
Diabetic kidney disease 2021Christos Argyropoulos
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesChristos Argyropoulos
 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerChristos Argyropoulos
 
Telenephrology
TelenephrologyTelenephrology
TelenephrologyChristos Argyropoulos
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationChristos Argyropoulos
 
ASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseChristos Argyropoulos
 
Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Christos Argyropoulos
 
Involuntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitInvoluntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitChristos Argyropoulos
 
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019Christos Argyropoulos
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Christos Argyropoulos
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itChristos Argyropoulos
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itChristos Argyropoulos
 
Relative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in DialysisRelative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in DialysisChristos Argyropoulos
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney DiseaseChristos Argyropoulos
 

More Related Content

More from Christos Argyropoulos

Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsChristos Argyropoulos
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesChristos Argyropoulos
 
Survival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsSurvival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsChristos Argyropoulos
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesChristos Argyropoulos
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesChristos Argyropoulos
 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerChristos Argyropoulos
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationChristos Argyropoulos
 
ASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseChristos Argyropoulos
 
Involuntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitInvoluntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitChristos Argyropoulos
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Christos Argyropoulos
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itChristos Argyropoulos
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itChristos Argyropoulos
 
Relative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in DialysisRelative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in DialysisChristos Argyropoulos
 

More from Christos Argyropoulos (20)

Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
 
Aldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseasesAldosterone in diabetes and other kidney diseases
Aldosterone in diabetes and other kidney diseases
 
Survival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive ModelsSurvival Analysis With Generalized Additive Models
Survival Analysis With Generalized Additive Models
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseases
 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with Cancer
 
Telenephrology
TelenephrologyTelenephrology
Telenephrology
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantation
 
ASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney DiseaseASK1 Inhibition in Diabetic Kidney Disease
ASK1 Inhibition in Diabetic Kidney Disease
 
Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019
 
Involuntary discharges from the dialysis unit
Involuntary discharges from the dialysis unitInvoluntary discharges from the dialysis unit
Involuntary discharges from the dialysis unit
 
Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019Update on diabetic nephropathy 2019
Update on diabetic nephropathy 2019
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
 
The aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about itThe aging kidney and what we should (not?) do about it
The aging kidney and what we should (not?) do about it
 
Relative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in DialysisRelative Blood Volume Monitoring and Applications in Dialysis
Relative Blood Volume Monitoring and Applications in Dialysis
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease